Publications by authors named "Honeylen M Tiu Teo"
Article Synopsis
- The study aimed to assess a minimally invasive surgical technique that combines endoscopic and eyelid crease approaches for treating recurrent sino-orbital mucoceles, in collaboration with oculoplastic and sinus surgeons.
- Review of 18 cases revealed that most patients had prior sinus or orbital surgeries, with complications such as cellulitis and proptosis, but only two cases (11%) of recurrence after an average follow-up of 19 months.
- The findings suggest that this surgical method is effective for advanced sino-orbital conditions, offering low recurrence rates and minimal complications.
Purpose: To report long-term outcomes of systemic rituximab therapy for idiopathic orbital inflammation (IOI) as both primary and salvage therapy and to review the English literature.
Methods: A retrospective review of four consecutive biopsy-proven IOI cases managed with systemic rituximab including demographics, management, and outcomes, and review of English literature, were performed. Primary outcome measures included resolution of symptoms, recurrence, and length of follow up.
Systemic anti-CD20 (rituximab) as primary treatment for symptomatic primary uveal lymphoma.
Am J Ophthalmol Case Rep
September 2019
Purpose: Uveal lymphomas are indolent, frequently choroid-involving neoplasms that are mainly CD20-positive B-cell extranodal marginal zone lymphoma. Irreversible visual loss may occur from retinal detachment and/or glaucoma among untreated symptomatic patients, or from radiation-induced changes secondary to external beam radiotherapy. To avoid radiation-induced complications, we used systemic rituximab monotherapy as primary treatment, and present two cases to show its long-term effectiveness for symptomatic primary uveal lymphoma.
View Article and Find Full Text PDF